6115 VEGF gene polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)

✍ Scribed by Loupakis, F.; Ruzzo, A.; Salvatore, L.; Canestrari, E.; Cremolini, C.; Santini, D.; Bencardino, K.; Manzoni, M.; Falcone, A.; Graziano, F.

• Book ID: 122864018
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 48 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71210-8